Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Donation - Other Level

Please use the quantity box to donate any amount you wish.

Contact Heather Mac Donald

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

Password Reset Request


Add a topic or expert to your feed.


Follow Experts & Topics

Stay on top of our work by selecting topics and experts of interest.

On The Ground
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed

Manhattan Institute

Close Nav
Share this project on Close

Project FDA

All Projects
Manhattan Institute health policy experts advocate for utilizing 21st century technologies to help improve FDA regulations and create a faster, safer drug and medical-device pipeline. Project FDA leads national efforts to meet health care challenges with more science, not more regulation.
Health PolicyFDA Reform


Katherine Lazarski


Project FDA Reports

Unlocking the Code of Health: Bridging the Gap Between Precision Medicine and FDA Regulation
by Peter W. Huber and Paul Howard, March 2014

Project FDA Committee

Andrew C. von Eschenbach, MD
Former Commissioner, U.S. Food and Drug Administration; Chairman, Project FDA; Former Director, National Cancer Institute

Tom Coburn, M.D.
Former Oklahoma Senator

John F. Crowley, JD, MBA
Chairman and CEO of Amicus Therapeutics, Inc.

Joseph DiMasi, PhD
Director of Economic Analysis, Tufts Center for the Study of Drug Development, Tufts University

Henry G. Grabowski, PhD
Professor Emeritus and Director of the Program in Pharmaceuticals and Health Economics, Duke University

James J. Hsieh, M.D., Ph.D.
Associate member, Memorial Sloan-Kettering Cancer Center; Co-Founder, MSK Translational Kidney Cancer Research Program; Associate Professor, Weill Cornell Medical College

Paul Howard, PhD
Senior Fellow and Director, Center for Medical Progress, Manhattan Institute

Peter Huber, PhD, JD
Senior Fellow, Manhattan Institute

Daniel P. Petrylak, MD
Director, Genitourinary Oncology, Co-Director Signal Transduction Program, Yale University Cancer Center

Tomas J. Philipson, PhD
Professor, Harris School for Public Policy, University of Chicago

Lance K. Stell, PhD, FACFE
John and Mary West Thatcher Professor of Philosophy, Davidson College

E. Fuller Torrey, MD
Executive Director, Stanley Medical Research Institute (SMRI) and founder of the Treatment Advocacy Center

Project FDA is a Manhattan Institute initiative that aims to reform the FDA to meet 21st century challenges. Under the leadership of former FDA commissioner Dr. Andrew von Eschenbach, Project FDA promotes reforms that can enable the FDA to offer a more predictable, transparent, and efficient pathway for bringing safe and effective new products to patients.

Medicine is on the cusp of a radical transformation. New sciences and technologies are poised to allow physicians to personalize treatment for every cancer patient; arrest or prevent the development of Alzheimer's disease; and radically lower health care costs by reducing the prevalence of expensive chronic diseases. Unfortunately, today's FDA has struggled to adapt its regulations to new scientific advances.

Project FDA believes the FDA can become a bridge for innovation, rather than a barrier to it, and that this can be achieved without sacrificing patient safety. For instance, advances in molecular medicine that allow companies to target specific sub-groups of patients, combined with electronic health records, should allow the FDA to streamline and improvetimeconsuming and expensive pre-market product testing that can take a decade or more, and implement vigorous post-market surveillance of "real world" patients after drugs or devices demonstrate safety and efficacy in early testing. This approach will not only accelerate access to innovative products; it should enhance efforts to safeguard public health.

Project FDA will educate the public on the FDA's vital role in advancing medical innovation; highlight the potential for new sciences to improve health while also lowering costs; and collaborate with patients' groups, industry stakeholders, and policymakers to modernize the FDA's policies and procedures.



0 items
Sort by Date
Sorry we were unable to find any results for “
Search suggestions
  • Make sure words are spelled correctly.
  • Try entering different keywords.
  • Try using more general keywords.
  • Try fewer keywords.